Antidepressants for pain management in rheumatoid arthritis (Q24235382)

PubMed

25 October 2023

2

Samuel L Whittle

Samuel L

Whittle

1 reference

PubMed

25 October 2023

Bethan L Richards

1

Bethan L

Richards

1 reference

PubMed

22071859

Cochrane Database of Systematic Reviews

25 October 2023

publication date

9 November 2011

0 references

published in

0 references

cites work

The effects of dothiepin on subjects with rheumatoid arthritis and depression.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Imipramine, rheumatoid arthritis and rheumatoid factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Psychomotor performance of patients with rheumatoid arthritis: cross-over comparison of dextropropoxyphene, dextropropoxyphene plus amitriptyline, indomethacin, and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Dose-response for analgesic effect of amitriptyline in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Clinical outcomes following a trial of sertraline in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Chronic pain, chronic stress and depression: coincidence or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Measurement of patient outcome in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

WITHDRAWN: Antidepressants for depression in medical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Molecular mechanisms of nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Self-reported sleep and mood disturbance in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Guidelines for the use of antidepressants in painful rheumatic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Antidepressant drugs as adjuvant analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Transcriptional and posttranslational plasticity and the generation of inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Epidemiology and burden of illness of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

Direct activation of rat spinal dorsal horn neurons by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

Imipramine in the Treatment of Rheumatic Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008920.PUB2

7 January 2021

10.1002/14651858.CD008920.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_tnfvq4norjc53li7p3gvnamz4y

0 references